Cargando…
Correction to: Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525326/ https://www.ncbi.nlm.nih.gov/pubmed/36040636 http://dx.doi.org/10.1007/s12325-022-02255-6 |
| _version_ | 1784800681483304960 |
|---|---|
| author | Liu, Yifei Skup, Martha Yang, Min Qi, Cynthia Z. Wu, Eric Q. |
| author_facet | Liu, Yifei Skup, Martha Yang, Min Qi, Cynthia Z. Wu, Eric Q. |
| author_sort | Liu, Yifei |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9525326 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95253262022-10-02 Correction to: Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018 Liu, Yifei Skup, Martha Yang, Min Qi, Cynthia Z. Wu, Eric Q. Adv Ther Correction Springer Healthcare 2022-08-30 2022 /pmc/articles/PMC9525326/ /pubmed/36040636 http://dx.doi.org/10.1007/s12325-022-02255-6 Text en © Springer Healthcare Ltd., part of Springer Nature 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Liu, Yifei Skup, Martha Yang, Min Qi, Cynthia Z. Wu, Eric Q. Correction to: Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018 |
| title | Correction to: Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018 |
| title_full | Correction to: Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018 |
| title_fullStr | Correction to: Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018 |
| title_full_unstemmed | Correction to: Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018 |
| title_short | Correction to: Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018 |
| title_sort | correction to: discontinuation and switchback after non-medical switching from originator tumor necrosis factor alpha (tnf) inhibitors to biosimilars: a meta-analysis of real-world studies from 2012 to 2018 |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525326/ https://www.ncbi.nlm.nih.gov/pubmed/36040636 http://dx.doi.org/10.1007/s12325-022-02255-6 |
| work_keys_str_mv | AT liuyifei correctiontodiscontinuationandswitchbackafternonmedicalswitchingfromoriginatortumornecrosisfactoralphatnfinhibitorstobiosimilarsametaanalysisofrealworldstudiesfrom2012to2018 AT skupmartha correctiontodiscontinuationandswitchbackafternonmedicalswitchingfromoriginatortumornecrosisfactoralphatnfinhibitorstobiosimilarsametaanalysisofrealworldstudiesfrom2012to2018 AT yangmin correctiontodiscontinuationandswitchbackafternonmedicalswitchingfromoriginatortumornecrosisfactoralphatnfinhibitorstobiosimilarsametaanalysisofrealworldstudiesfrom2012to2018 AT qicynthiaz correctiontodiscontinuationandswitchbackafternonmedicalswitchingfromoriginatortumornecrosisfactoralphatnfinhibitorstobiosimilarsametaanalysisofrealworldstudiesfrom2012to2018 AT wuericq correctiontodiscontinuationandswitchbackafternonmedicalswitchingfromoriginatortumornecrosisfactoralphatnfinhibitorstobiosimilarsametaanalysisofrealworldstudiesfrom2012to2018 |